Providencia rustigianii

(aka Providencia alcalifaciens Biogroup 3)

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Providencia rustigianii, (aka Providencia alcalifaciens Biogroup 3), is a Gram-negative, non-spore-forming, facultatively anaerobic, variably-motile, rod-shaped bacterium. It has been detected in at least 4 gut microbiome compilation studies or metastudies. The DNA G+C content is 41.8%. Providencia rustigianii is probably a rare gut coloniser. (Farmer1985; Ewing1962; HickmanBrenner1983; O'Hara2000; Penner2005aBergey)



  • This organism has been recovered from human faeces, and clinical sources (urine - CCUG). The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread. Is a rare opportunistic pathogen. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Farmer1985); (Ewing1962); (HickmanBrenner1983); (O'Hara2000); (Penner2005aBergey);
    Character Response
  • Substrates hydrolysed or digested:
  • tyrosine;
  • 🌡
  • Temperature tolerance:
  • Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • galactose; glucose; mannose; xylose;
  • ⥅
  • Substrates assimilated or utilised:
  • D-tartrate; L-tartrate;
  • Active enzymes:
  • phenylalanine deaminase;
    • SPECIAL FEATURES (Farmer1985); (Ewing1962); (HickmanBrenner1983); (O'Hara2000); (Penner2005aBergey);
    Character Response
  • ✓
  • Metabolites produced:
  • indole;
  • ✗
  • Metabolites not produced:
  • H₂S;
  • ±
  • Methyl red test:
  • strain dependent
  • ✗
  • VP test:
  • not active
  • ✗
  • ONPG test:
  • not active
  • KCN growth:
  • growth observed
  • ✓
  • NO3➔NO2:
  • reduced
    • RESPONSE TO ANTIBIOTICS (HickmanBrenner1983); (O'Hara2000); (Penner2005aBergey);
    Class Active Resistant
  • Penicillins:
  • ampicillin; carbenicillin; ertapenem; imipenem; piperacillin-tazobactam;
  • penicillin;
  • Cephalosporins:
  • ceftazidime; cephalothin;
  • Tetracyclines:
  • tetracycline;
  • Quinolines:
  • ciprofloxacin; levofloxacin; moxifloxacin; nalidixic-acid;
  • Aminoglycosides:
  • amikacin; gentamicin; kanamycin; streptomycin;
  • Heterocycles:
  • chloramphenicol;
  • Miscellaneous antibiotics:
  • colistin;

  • Müller, H. E. (1986). Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces. Journal of Clinical Microbiology, 23(2), 404–405.

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Gammaproteobacteria Order:  Enterobacterales Family:  Enterobacteriaceae Genus:  Providencia Alt. name:  Providencia alcalifaciens Biogroup 3 Gram stain:  neg O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  vr Morphology:  Rod
    Health:  Unknown
    Source:  human faeces, and clinical sources (urine - CCUG)
    DNA G+C(%):  41.8
    Opt. T:  37℃
    		Aesculin:  neg Urea:  neg Gelatin:  neg DNA:  neg Tyrosine:  +
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg D-Arabinose:  neg L-Arabinose:  neg Galactose:  + Glucose:  + Mannose:  + Rhamnose:  neg Xylose:  + Cellubiose:  neg Lactose:  neg Maltose:  neg Sucrose:  w Trehalose:  neg Amygdalin:  neg Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  w Inositol:  neg Mannitol:  neg Sorbitol:  neg 5-Ketogluconate:  neg Me-α-D-Glc:  neg Salicin:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Melibiose:  neg Acetate:  neg Citrate:  neg Malonate:  neg Mucate:  neg D-Tartrate:  d(+) L-Tartrate:  d(+)
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Urease:  neg Ac-β-glcamnd:  neg α-Galactosidase:  neg β-Galactosidase:  neg α-Glucosidase:  neg β-Glucosidase:  neg β-Glucuronidase:  neg ArgDH:  neg ArgDC:  neg LysDC:  neg OrnDC:  neg Phe deaminase:  + DNAse:  neg Lipase:  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  neg Indole:  +
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  S(10,vr; disc)
    carbenicil:  S(100; disc)
    penicillin:  R(10U; disc)
    piper-taz:  S(≤1/≤1)
    ertapenem:  S(≤0.125/≤0.125)
    imipenem:  S(4/4)
    ceftazidime:  S(≤0.5/8)
    cephalothin:  S(30,vr; disc)
    amikacin:  S(≤2/≤2)
    gentamicin:  S(≤2/≤8)
    kanamycin:  S(30; disc)
    streptomycin:  S(10,vr; disc)
    ciprofloxacin:  S(≤0.5/≤0.5)
    levofloxacin:  S(≤0.5/≤0.5)
    moxifloxacin:  S(≤0.25/2)
    nalidixic-acid:  S(30,vr; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  S(30,vr; disc)
    chloramphenicol:  S(30; disc)
    colistin:  R(10; disc)

    References

    SPECIFIC REFERENCES FOR PROVIDENCIA RUSTIGIANII
  • Farmer1985 - Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.
  • Ewing1962 - The tribe Proteeae: its nomenclature and taxonomy.
  • HickmanBrenner1983 - Providencia rustigianii: a new species in the family Enterobacteriaceae formerly known as Providencia alcalifaciens biogroup 3.
  • O'Hara2000 - Classification, Identification, and Clinical Significance of Proteus, Providencia and Morganella.
  • Penner2005aBergey - Bergey's manual of systematic bacteriology. Vol. 2, The Gammaproteobacteria Part B. Family Enterobacteriaceae, Genus XXX. Providencia
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR PROVIDENCIA RUSTIGIANII
  • Forster2019 - A human gut bacterial genome and culture collection for improved metagenomic analyses.
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • Tyakht2013 - Human gut microbiota community structures in urban and rural populations in Russia.
  • ...............................
    • GENERAL REFERENCES FOR PROVIDENCIA RUSTIGIANII
  • CCUG - Culture Collection University of Gothenburg - Entire Collection
    • Added: April 08, 2021